104. Psychedelics in New Zealand with Dr Suresh Muthukumaraswamy The Drug Science Podcast

 In this episode, we meet with Dr. Suresh Muthukumaraswamy, an Associate Professor of Pharmacy in Auckland. Dr. Muthukumaraswamy discusses his early research, exploring the functional connectivity of substances like DMT and Ketamine. He proceeds to share insights into his breakthrough realisation regarding the disparity between the self-reported success of microdosing outside the lab setting and why it has failed to be replicated in controlled research settings. Finally, he shares his opinions on recent developments of drug policy in Australia and the prospects of New Zealand adopting a similar policy.
Ketamine
DMT
LSD
Fmri
MEG
EEG
PET
5-HT Receptor
Microdosing
Neuroplasticity
Endocrine
Menstural Cycle Hormones
Australia Law on MDMA and Psilocybin
Research
Support the podcast


★ Support this podcast ★